Synthesis and characterization of anti-infective agents

Authors

  • Monika Sharma Maharishi Arvind College of Pharmacy, Ambabari Circle, Ambabari, Jaipur
  • Sonu Sharma School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur
  • Neha Arora School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur
  • Shreya Sharma School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur
  • Yogesh Matta School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur
  • Sharad Sharma School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur

DOI:

https://doi.org/10.18231/j.joapr.2019.v.7.i.4.002

Keywords:

Detrimental, colonization, microorganism, concentration, anti-infective agents

Abstract

Antifungal chemotherapy depends on bio-chemical alterations between fungi and mammals. Unlike bacteria, which are prokaryotes, both fungi and mammals are eukaryotes and the biochemical differences between them are not significant. However, there are some differences (in structure & metabolism) and focus is on these differences that act as targets for development of antifungal agents. The current recommendation of standard TB chemotherapy, called Directly observed treatment (DOTS) is a therapy of six month  in which consists an first two-month phase of cure with four first-line drugs i.e. isoniazid, Rifampicin, Pyrazinamide, and Ethambutol. In this study large number of compounds is manufactured in which Most of the tested molecules showed maximum bacteriological growth inhibition at tested concentration. The combinations (7e, 7g, 7h, 7i and 7u) exhibited bacteriological growth inhibition at concentration of less than 40.0μg/ml against both microorganisms. Compounds (7o) showed growth of inhibition at 2.5μg/ml against both microorganisms. Additional challenging for all compounds at lower concentrations is mandatory to compare their activity through standard Streptomycin at its MIC to get exact MIC the manufactured combinations. Thus it can be concluded that designed 1, 3, 4-oxadiazole derivatives (7a-v) were manufactured successfully using planned synthetic outline. After manufactured the molecules were characterized using spectroscopy analysis and tested for the biological activity. All combinations showed anti-bacterial action at tested concentration against both gram positive and gram negative organisms and one of the compound 7o showed activity at concentration <2.5 μg/ml. Thus, these 1, 3, 4-oxadiazole results can then act as a potential principal for drug discovery of novel anti-infective agents.

Downloads

Download data is not yet available.

References

Plattener, J., Chiron, C. Cancer and Infectious diseases. Annual Reports in Medicinal Chemistry, Elsevier Academic press, New York, pp. 163-172.

William O Foye, Thomas L Lemke, David A Williams, Foye’s Principles of Medicinal Chemistry. Fifth Edition, Philadelphia: Lippincott Williams and Wilkins, pp. 904-923, 2002

Harikishan Singh and V. K. Kapoor’s, Medicinal and Pharmaceutical Chemistry. First Edition, Vallabh Publications, pp. 476-481, 2000

Burger’s, Medicinal Chemistry and Drug Discovery. Fifth Edition, Vol.2, A Willy interscience publications, pp. 575-635, 1995

Tripathi, K.D, Essentials of Medical Pharmacology. Fifth Edition, Published by Jaypee Brothers Medical Publishers (P) Ltd. New Delhi, pp. 671-824, 2000

K. Duncan, Identification and Validation of Novel Drug Targets in Tuberculosis. Current Pharmaceutical Design, volume 10, pp. 3185-3194, 2004

Nelson, J. M., Chiller, T. M,Powers, J. H., Angulo, F. J. Food Safety, Fluoro quinolone‐Resistant Campylobacter Species and the Withdrawal of Fluoro quinolones from Use in Poultry. A Public Health Success Story. Clinical Infectious Diseases. Volume 44 (7), pp. 977–80, 2007

Published

2019-12-30

How to Cite

Sharma, M., Sharma, S., Arora, N., Sharma, S. ., Matta, Y., & Sharma, S. (2019). Synthesis and characterization of anti-infective agents. Journal of Applied Pharmaceutical Research, 7(4), 07-18. https://doi.org/10.18231/j.joapr.2019.v.7.i.4.002

Issue

Section

Articles